Acquisition of APIRx
For personal use only
APIRx expertise in Drug Delivery Systems
Ideal Delivery System Characteristics
Improved / similar Pharmacokinetic (PK)/Pharmacodynamic (PD)
profile to smoked form.
Broader Therapeutic Index.
Control of release depending on indications (rapid vs. depot).
Existing Forms of Delivery
Smoking - rapid onset and decline, socially unacceptable.
Oral spray (SativexTM) - solution contains alcohol and other
ingredients to cause dry mouth.
-
Ingestible (tablets, capsules, oils and edibles) - low bioavailability,
gastrointestinal complaints.
Incannex
Provision of additional benefits besides the ones
directly attributed to the API (functionality).
Reduced cost.
Transmucosal, Controlled Release (CanChew™,
CanChew Plus™, MedChew™, HempChew™)
Suppositories (SuppoCann controlled release
of API)
- Oral topical: Oraximax™
- Transdermal: ReneCann™, Cannonych™, Cannamycin™
- Transconjunctival: OphtoCann™, CannBleph™
Property of APIRX
APIRX forms of delivery
potentially applicable to Incannex
drug combinations.
Shareholder Presentation
13View entire presentation